QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 215 filers reported holding QIAGEN NV in Q4 2017. The put-call ratio across all filers is 2.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $3,000 | +50.0% | 56 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 56 | 0.0% | 0.00% | -100.0% |
Q1 2020 | $2,000 | -60.0% | 56 | -62.7% | 0.00% | 0.0% |
Q4 2019 | $5,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $5,000 | -80.0% | 150 | -78.0% | 0.00% | -83.3% |
Q2 2019 | $25,000 | +316.7% | 681 | +354.0% | 0.01% | +500.0% |
Q1 2019 | $6,000 | -73.9% | 150 | -78.0% | 0.00% | -80.0% |
Q4 2018 | $23,000 | -8.0% | 681 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $25,000 | +4.2% | 681 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $24,000 | -52.0% | 681 | -55.7% | 0.01% | -54.5% |
Q1 2018 | $50,000 | +4.2% | 1,538 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $48,000 | – | 1,538 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |